Zhengye Biotechnology Holding Limited (ZYBT) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Zhengye Biotechnology Holding Limited (ZYBT) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $41.2M, listed on NASDAQ, employing roughly 278 people, carrying a beta of -2.45 to the broader market. Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. Led by Songlin Song, public since 2025-01-07.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for ZYBT as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →